Healthcare providers will check your blood tests and symptoms to determine the right dose and frequency
Goodman WG, Quarles LD (2008) Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics
Last updated 3/22/2013
Kraus D, Yang Q, Kong D, Banks AS, Zhang L, Rodgers JT, Pirinen E, Pulinilkunnil TC, Gong F, Wang YC, Cen Y, Sauve AA, Asara JM, Peroni OD, Monia BP, Bhanot S, Alhonen L, Puigserver P, Kahn BB. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. 2014 Apr 10;508(7495):258-62. doi: 10.1038/nature13198. PMID: 24717514; PMCID: PMC4107212
Indications: Overactive bladder Common symptoms include urgency, urinary incontinence, and increased urinary frequency Side Effects: urinary retention pruritus, rash constipation Pharmacokinetics: taken orally by tablet, 75 mg once daily hepatic metabolism predominantly by CYP3A4 vibegron does not inhibit CYP2D6 (unlike mirabegron), so its pattern of drug interactions differs from mirabegron vibegron is a P-gp substrate half life ~31 hours Drug Interactions: increases digoxin Cmax (21%) and AUC (11%) Notes: Vibegron is a newly approved drug, and the estimated Walmart cost for Gemtesa oral 75mg tablets is ~$485 for a supply of 30 tablets (GoodRx.com
repeated dosing produced sustained IGF-I elevation for weeks
